Skip to main content
. 2016 Apr 18;7(20):29720–29738. doi: 10.18632/oncotarget.8825

Figure 2. Identification of the relapse-related lncRNA signature in the discovery dataset.

Figure 2

A. The learning errors for top N-lncRNA model using 5-fold cross-validation procedures with 100 random partitions of the discovery dataset. B. The variance rate of classification accuracy when increasing numbers of the predictive lncRNAs. C. ROC analysis of the relapse-related lncRNA signature for relapse prediction within five years as the defining point. D. Kaplan-Meier survival curve for RFS of patients with relapse or relapse-free according to nine-lncRNA model-based prediction.